Oxidant stress regulatory genetic variation in recipients and donors contributes to risk of primary graft dysfunction after lung transplantation
- PMID: 25439478
- PMCID: PMC4346512
- DOI: 10.1016/j.jtcvs.2014.09.077
Oxidant stress regulatory genetic variation in recipients and donors contributes to risk of primary graft dysfunction after lung transplantation
Abstract
Objective: Oxidant stress pathway activation during ischemia reperfusion injury may contribute to the development of primary graft dysfunction (PGD) after lung transplantation. We hypothesized that oxidant stress gene variation in recipients and donors is associated with PGD.
Methods: Donors and recipients from the Lung Transplant Outcomes Group (LTOG) cohort were genotyped using the Illumina IBC chip filtered for oxidant stress pathway genes. Single nucleotide polymorphisms (SNPs) grouped into SNP sets based on haplotype blocks within 49 oxidant stress genes selected from gene ontology pathways and literature review were tested for PGD association using a sequencing kernel association test. Analyses were adjusted for clinical confounding variables and population stratification.
Results: Three hundred ninety-two donors and 1038 recipients met genetic quality control standards. Thirty percent of patients developed grade 3 PGD within 72 hours. Donor NADPH oxidase 3 (NOX3) was associated with PGD (P = .01) with 5 individual significant loci (P values between .006 and .03). In recipients, variation in glutathione peroxidase (GPX1) and NRF-2 (NFE2L2) was significantly associated with PGD (P = .01 for both). The GPX1 association included 3 individual loci (P values between .006 and .049) and the NFE2L2 association included 2 loci (P = .03 and .05). Significant epistatic effects influencing PGD susceptibility were evident between 3 different donor blocks of NOX3 and recipient NFE2L2 (P = .026, P = .017, and P = .031).
Conclusions: Our study has prioritized GPX1, NOX3, and NFE2L2 genes for future research in PGD pathogenesis, and highlights a donor-recipient interaction of NOX3 and NFE2L2 that increases the risk of PGD.
Copyright © 2015 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
The author(s) declare that they have no competing interests.
Figures


Comment in
-
One step closer to the elimination of primary graft dysfunction.J Thorac Cardiovasc Surg. 2015 Feb;149(2):602-3. doi: 10.1016/j.jtcvs.2014.10.010. Epub 2014 Oct 7. J Thorac Cardiovasc Surg. 2015. PMID: 25457258 Free PMC article. No abstract available.
References
-
- Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D, et al. Report of the ishlt working group on primary lung graft dysfunction part ii: Definition. A consensus statement of the international society for heart and lung transplantation. J Heart Lung Transplant. 2005;24:1454–9. - PubMed
-
- Christie JD, Edwards LB, Kucheryavaya AY, Aurora P, Dobbels F, Kirk R, et al. The registry of the international society for heart and lung transplantation: Twenty-seventh official adult lung and heart-lung transplant report--2010. J Heart Lung Transplant. 2010;29:1104–18. - PubMed
-
- Daud SA, Yusen RD, Meyers BF, Chakinala MM, Walter MJ, Aloush AA, et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2007;175:507–13. - PubMed
-
- Zhang YX, Fan H, Shi Y, Xu ST, Yuan YF, Zheng RH, et al. Prevention of lung ischemia-reperfusion injury by short hairpin rna-mediated caspase-3 gene silencing. J Thorac Cardiovasc Surg. 2010;139:758–64. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R0IGM088566/PHS HHS/United States
- HL115354/HL/NHLBI NIH HHS/United States
- R01 HL087115/HL/NHLBI NIH HHS/United States
- R01 HL081619/HL/NHLBI NIH HHS/United States
- K12 HL090021/HL/NHLBI NIH HHS/United States
- HL087115/HL/NHLBI NIH HHS/United States
- HL090021/HL/NHLBI NIH HHS/United States
- R01 GM088566/GM/NIGMS NIH HHS/United States
- HL096845/HL/NHLBI NIH HHS/United States
- K24 HL115354/HL/NHLBI NIH HHS/United States
- HL116656/HL/NHLBI NIH HHS/United States
- R01 HL114626/HL/NHLBI NIH HHS/United States
- K23 HL116656/HL/NHLBI NIH HHS/United States
- R01 HL096845/HL/NHLBI NIH HHS/United States
- HL114626/HL/NHLBI NIH HHS/United States
- HL081619/HL/NHLBI NIH HHS/United States
- K23 HL121406/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous